Immunocore Holdings (IMCR) Earnings Date & Reports
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMCR is expected to report earnings to fall 17.98% to -38 cents per share on May 07
Q1'25
Est.
$-0.39
Q4'24
Missed
by $0.23
Q3'24
Beat
by $0.50
Q2'24
Beat
by $0.25
Q1'24
Missed
by $0.12
The last earnings report on February 26 showed earnings per share of -46 cents, missing the estimate of -23 cents. With 75.25K shares outstanding, the current market capitalization sits at 1.47B.